Zomedica (ZOM) News Today $0.13 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Noble Financial Comments on Zomedica FY2024 EarningsZomedica Corp. (NYSEAMERICAN:ZOM - Free Report) - Analysts at Noble Financial issued their FY2024 earnings estimates for shares of Zomedica in a research report issued on Monday, November 11th. Noble Financial analyst R. Leboyer anticipates that the company will post earnings per share of ($0.05)November 14, 2024 | marketbeat.comJohnny D. Powers Buys 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockNovember 13, 2024 | insidertrades.comNoble Financial Upgrades Zomedica (NYSEAMERICAN:ZOM) to Strong-BuyNovember 13, 2024 | americanbankingnews.comZomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Acquires 100,000 SharesZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) Director Johnny D. Powers acquired 100,000 shares of Zomedica stock in a transaction dated Monday, November 11th. The stock was purchased at an average price of $0.12 per share, with a total value of $12,000.00. Following the completion of the purchase, the director now owns 2,425,000 shares of the company's stock, valued at approximately $291,000. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.November 12, 2024 | marketbeat.comZomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble FinancialNoble Financial upgraded Zomedica to a "strong-buy" rating in a research report on Monday.November 12, 2024 | marketbeat.comZomedica Corp.: Noble Capital Markets Initiates Equity Research Coverage on ZomedicaNovember 12, 2024 | finanznachrichten.deZomedica Positioned for Growth with Strategic Acquisitions and Strong Financial Performance: Buy RecommendationNovember 11, 2024 | markets.businessinsider.comZomedica Corp Posts Increased Revenue Amid LossNovember 9, 2024 | markets.businessinsider.comZomedica’s Revenue Up 10% Amid Global ExpansionNovember 9, 2024 | markets.businessinsider.comZomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...November 8, 2024 | finance.yahoo.comZomedica Corp. (ZOM) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comZomedica Corp. ZOM (U.S.: NYSE American)October 22, 2024 | wsj.comZomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue ChallengesOctober 9, 2024 | finance.yahoo.comZomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA ReachOctober 3, 2024 | benzinga.comZomedica Corp.: Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, MinnesotaSeptember 11, 2024 | finanznachrichten.deInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) CEO Acquires 100,000 Shares of StockSeptember 6, 2024 | insidertrades.comZomedica Corp. (NYSEAMERICAN:ZOM) CEO Larry C. Heaton II Buys 100,000 SharesZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) CEO Larry C. Heaton II purchased 100,000 shares of Zomedica stock in a transaction on Thursday, September 5th. The stock was bought at an average cost of $0.12 per share, for a total transaction of $12,000.00. Following the transaction, the chief executive officer now directly owns 400,000 shares in the company, valued at $48,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.September 5, 2024 | marketbeat.comJohnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockAugust 29, 2024 | insidertrades.comZomedica Corp.: Zomedica's Assisi Loop Product Line Designated as Fear Free Preferred ProductAugust 29, 2024 | finanznachrichten.deZomedica Corp. (NYSEAMERICAN:ZOM) Director Buys $13,000.00 in StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) Director Johnny D. Powers bought 100,000 shares of the stock in a transaction dated Wednesday, August 28th. The shares were acquired at an average price of $0.13 per share, with a total value of $13,000.00. Following the completion of the purchase, the director now directly owns 2,325,000 shares of the company's stock, valued at $302,250. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.August 28, 2024 | marketbeat.comWORK Medical Technology Group LTD Ordinary Shares (WOK)August 23, 2024 | sg.finance.yahoo.comZomedica Corp.: Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary ConferenceAugust 20, 2024 | finanznachrichten.deZomedica (NYSEAMERICAN:ZOM) Stock Price Down 5.5%Zomedica (NYSEAMERICAN:ZOM) Trading Down 5.5%August 16, 2024 | marketbeat.comZOM Stock Earnings: Zomedica Misses Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comZomedica Taps Into Costa Rica With Strategic Partnership With SIRE VeterinarioAugust 14, 2024 | msn.comZomedica Corp.: Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central AmericaAugust 14, 2024 | finanznachrichten.deZomedica Corp.: The United States Eventing Association Names Zomedica's PulseVet as the Official Shock Wave of the USEAJuly 19, 2024 | finanznachrichten.deZomedica Corp. (NYSEAMERICAN:ZOM) VP Russell Kevin Klass Buys 299,993 SharesJune 14, 2024 | insidertrades.comRussell Kevin Klass Buys 299,993 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) VP Russell Kevin Klass purchased 299,993 shares of the company's stock in a transaction dated Wednesday, June 12th. The stock was acquired at an average price of $0.16 per share, with a total value of $47,998.88. Following the completion of the transaction, the vice president now owns 2,000,050 shares of the company's stock, valued at approximately $320,008. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.June 13, 2024 | marketbeat.comThe 3 Most Undervalued Penny Stocks to Buy in June 2024June 13, 2024 | investorplace.comZomedica Corp.: Zomedica Enhances TRUFORMA Platform With Launch of Advanced Canine Cortisol AssayMay 29, 2024 | finanznachrichten.deZomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol AssayMay 29, 2024 | finance.yahoo.comZomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) TherapyMay 23, 2024 | finance.yahoo.comZomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 21, 2024 | finance.yahoo.comInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) Director Purchases 100,000 Shares of StockMay 18, 2024 | insidertrades.comZomedica Corp. (NYSEAMERICAN:ZOM) COO Anthony K. Blair Buys 150,000 SharesMay 15, 2024 | insidertrades.comInsider Buying: Zomedica Corp. (NYSEAMERICAN:ZOM) COO Buys 150,000 Shares of StockZomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report) COO Anthony K. Blair purchased 150,000 shares of the stock in a transaction dated Monday, May 13th. The shares were bought at an average price of $0.14 per share, with a total value of $21,000.00. Following the completion of the acquisition, the chief operating officer now directly owns 150,000 shares of the company's stock, valued at approximately $21,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.May 14, 2024 | marketbeat.comZomedica And 3 Other Stocks Under $3 Insiders Are BuyingMay 14, 2024 | msn.comLarry C. Heaton II Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) StockMay 14, 2024 | insidertrades.comZomedica Corp (ZOM) Q1 2024 Earnings: Revenue Climbs Amidst Rising Costs, Aligns with Analyst ...May 10, 2024 | finance.yahoo.comZomedica earnings: here's what Wall Street expectsMay 9, 2024 | markets.businessinsider.comZomedica Corp.: Zomedica Expands International Reach with CE Certification for VetGuardian SystemMay 6, 2024 | finanznachrichten.deZomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call TranscriptApril 2, 2024 | msn.comQ4 2023 Zomedica Corp Earnings CallApril 2, 2024 | finance.yahoo.comZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023April 1, 2024 | investorplace.comZomedica reports Q4 resultsApril 1, 2024 | msn.comThe Next Millionaire-Makers: 3 Penny Stocks With Massive Upside PotentialApril 1, 2024 | investorplace.comZomedica Pharmaceuticals Corp (ZOM)March 15, 2024 | investing.comSidoti & Company, LLC: Sidoti Events, LLC's Virtual March Small-Cap ConferenceMarch 12, 2024 | finanznachrichten.deZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary ConferencesMarch 12, 2024 | finanznachrichten.de Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. ZOM Media Mentions By Week ZOM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZOM News Sentiment▼1.100.46▲Average Medical News Sentiment ZOM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZOM Articles This Week▼41▲ZOM Articles Average Week Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MREO News ARCT News ALMS News YMAB News ZVRA News ESPR News RGNX News SLRN News MGTX News XERS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:ZOM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
